ATE376840T1 - Gentherapeutika - Google Patents

Gentherapeutika

Info

Publication number
ATE376840T1
ATE376840T1 AT00908055T AT00908055T ATE376840T1 AT E376840 T1 ATE376840 T1 AT E376840T1 AT 00908055 T AT00908055 T AT 00908055T AT 00908055 T AT00908055 T AT 00908055T AT E376840 T1 ATE376840 T1 AT E376840T1
Authority
AT
Austria
Prior art keywords
gene
affinity
functional substance
efficacious amount
gene therapeutics
Prior art date
Application number
AT00908055T
Other languages
English (en)
Inventor
Ikunoshin Kato
Kiyozo Asada
Mitsuhiro Ueno
Kimikazu Hashino
Hirofumi Yoshioka
Keiji Tanaka
Original Assignee
Takara Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takara Bio Inc filed Critical Takara Bio Inc
Application granted granted Critical
Publication of ATE376840T1 publication Critical patent/ATE376840T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00908055T 1999-03-23 2000-03-14 Gentherapeutika ATE376840T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7859199 1999-03-23

Publications (1)

Publication Number Publication Date
ATE376840T1 true ATE376840T1 (de) 2007-11-15

Family

ID=13666162

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00908055T ATE376840T1 (de) 1999-03-23 2000-03-14 Gentherapeutika

Country Status (9)

Country Link
US (1) US20060166924A1 (de)
EP (1) EP1163912B1 (de)
KR (1) KR100674140B1 (de)
CN (1) CN1225285C (de)
AT (1) ATE376840T1 (de)
AU (1) AU2944100A (de)
DE (1) DE60036929T2 (de)
TW (1) TWI272107B (de)
WO (1) WO2000056368A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101633907B (zh) 2001-08-15 2012-09-05 宝生物工程株式会社 抗原特异性细胞毒性t细胞的扩大培养方法
DE60335253D1 (de) 2002-03-25 2011-01-20 Takara Bio Inc Verfahren zur produktion eines zytotoxischen lymphozyten
DE602004025591D1 (de) 2003-08-22 2010-04-01 Takara Bio Inc Verfahren zur herstellung zytotoxischer lymphozyten
WO2007020880A1 (ja) 2005-08-17 2007-02-22 Takara Bio Inc. リンパ球の製造方法
EP1939278A4 (de) * 2005-09-30 2009-06-03 Takara Bio Inc Verfahren zur herstellung einer t-zellpopulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686278A (en) * 1994-03-25 1997-11-11 Indiana University Foundation Methods for enhanced retrovirus-mediated gene transfer
JPH09509329A (ja) * 1994-05-13 1997-09-22 チロン ビアジーン，インコーポレイティド 遺伝子搬送媒体を標的とする組成物及び方法
GB9506466D0 (en) * 1994-08-26 1995-05-17 Prolifix Ltd Cell cycle regulated repressor and dna element
FR2726005B1 (fr) * 1994-10-10 1997-01-03 Adim Lignees immortalisees de cellules endotheliales cerebrales et leurs applications au traitement de differents troubles ou maladies primaires et secondaires neurologiques ou psychiatriques
KR100353115B1 (ko) * 1995-11-13 2003-01-06 다카라츠죠 가부시키가이샤 레트로바이러스를사용한표적세포내로의유전자도입방법
WO1997031656A1 (fr) * 1996-03-01 1997-09-04 Dnavec Research Inc. Composition pour introduire de maniere stable des genes dans des cellules hepatiques et procede pour introduire des genes a l'aide de cette composition
CN1190496C (zh) * 1998-07-01 2005-02-23 宝生物工程株式会社 基因导入的方法

Also Published As

Publication number Publication date
AU2944100A (en) 2000-10-09
DE60036929D1 (de) 2007-12-13
CN1225285C (zh) 2005-11-02
DE60036929T2 (de) 2008-08-07
KR100674140B1 (ko) 2007-01-26
KR20010102547A (ko) 2001-11-15
TWI272107B (en) 2007-02-01
US20060166924A1 (en) 2006-07-27
CN1345248A (zh) 2002-04-17
EP1163912A4 (de) 2003-08-06
EP1163912A1 (de) 2001-12-19
WO2000056368A1 (fr) 2000-09-28
EP1163912B1 (de) 2007-10-31

Similar Documents

Publication Publication Date Title
DK0774005T3 (da) Overfladeudtrykkelse af enzymer i genorienteret prodrug-terapi
DE50211045D1 (de) Medizinische aerosolformulierungen
HN1998000143A (es) Tetrahidronaftalenos substituidos y compuestos analogos.
TR199800046A2 (xx) Aktif maddeler yarat�lmas� i�in n�kleik asit olu�umu.
NL980011I2 (nl) 7-Piperazinyl- of 7-Morfolino-4-oxo-chinoline-3-carbonzuurderivaten, hun bereiding en hun gebruik als antimicrobiële middelen.
SV2002000245A (es) Oxazolidinonas substituidas y su uso ref. lea 34122-sv
ATE231509T1 (de) 1,5-dihydro-pyrazolo 3,4-d)-pyrimidinon-derivate
PT751939E (pt) Naftilamidas como agentes para o sistema nervoso central
TR200200883T2 (tr) 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları
DE60016798D1 (de) Papiertuch enthaltend antivirale wirkstoffe die hautfreundlich sind
BR0009170A (pt) ácidos nucléicos akt, polipeptìdeos e uso dos mesmos
SE0102147D0 (sv) New methods
NO20041773L (no) Farmasoytiske preparater for reduksjon av cellers aktivitet samt deres anvendelse.
ATE376840T1 (de) Gentherapeutika
DE60142899D1 (de) Verbindungen für den transfer von oligonukleotiden
ATE172721T1 (de) Aminosäurederivate und ihre verwendung als enkephalinase-inhibitoren
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
DK52685D0 (da) N,3-diacyl-2-oxindol-1-carboxamid-forbindelser og mellemprodukter ved deres fremstilling samt farmaceutisk praeparat
BRPI0409683A (pt) 5-hidroxiindóis com grupos n-óxido e seu emprego como agentes terapêuticos
ATE305612T1 (de) Reporterverbindungen und verfahren zur auffindung von hochspezifische proteaseaktivität
NL350033I1 (nl) Gefuseerde middelen voor biologische controle.
CY1107346T1 (el) Φαρμακευτικη συνθεση για την ενδοκυτταρια οξινιση με cis-ουροκανικο οξυ
DK592885A (da) 2-azolylmethyl-3-difluorbenzyloxy-2,3-dihydrofluor-benzo(b)thiophener, fremgangsmaade til deres fremstilling og kompositioner indeholdendeforbindelserne
MEP18508A (en) Pharmaceutical composition and preparation thereof
BR9915897A (pt) Agentes de transferência de ácidos nucleicos, composição, utilização de um agente de transferência e processos de tratamento de corpo humano ou animal e de transferência de ácidos nucleicos.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties